René V.
- Country
- France
- Department
- Endocrinology
Research Overview
- Evaluation of ISIS 678354 Sodium Salt in Patients with Severe Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial
- Phase 3 Double-Blind, Placebo-Controlled Study on the Efficacy and Safety of Plozasiran in Adults with Hypertriglyceridemia
- Evaluation of Efficacy and Safety of ARO-APOC3 in Adults with Familial Chylomicronemia Syndrome: A Phase 3 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 157 of 303 partner sites.
Specializations
Lipid Disorders
The investigator specializes in treating patients with severe lipid metabolism disorders, particularly focusing on severe hypertriglyceridemia (SHTG) and familial chylomicronemia syndrome (FCS).
- Triglyceride Management
- Genetic Lipid Disorders
- Metabolic Disease Treatment
Their expertise extends to evaluating novel therapeutic approaches for managing elevated triglyceride levels.
Innovative Therapeutics
The investigator works with advanced therapeutic agents including olezarsen, plozasiran, and pegozafermin for treating severe lipid disorders.
- Novel Drug Development
- Targeted Therapies
- Therapeutic Assessment
Their work involves evaluating the safety and efficacy of emerging treatments for metabolic conditions.
Clinical Applications
The investigator focuses on long-term management strategies for patients with severe lipid disorders, including both genetic and acquired forms of hypertriglyceridemia.
- Treatment Optimization
- Patient Monitoring
- Clinical Outcomes
Their expertise includes evaluating therapeutic responses in patients with complex lipid disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.